Rimedio Pharma Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2020.
2020 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Rimedio Pharma Private Limited

Rimedio Pharma Private Limited, a struck off private limited company, was established on 26 March 2020 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909MH2020PTC339123. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Amit Mangilal Bishnoi (Additional Director), Satyendra Tiwari (Additional Director), Kaushik Balakrishnan Natesan (Director). Past directors included Akshay Jain, Abhitesh Kumar, Prabhat Agrawal. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No. 605/606, 6Th Floor, Trade Centre Bandra Kurla Complex, Bandra East Mumbai, Mumbai, Maharashtra, 400051.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909MH2020PTC339123

  • Registration Number

    339123

  • Incorporation Date

    26 March 2020

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** %
  • Profit Growth **** -100.00%
  • Ebitda **** -75.00%
  • Net Worth -400.00%
  • Total Assets -50.00%
Company report

Rimedio Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rimedio Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rimedio Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Amit Mangilal Bishnoi Additional Director 26 Mar 2024 Current
Satyendra Tiwari Additional Director 10 Feb 2025 Current
Kaushik Balakrishnan Natesan Director 26 Mar 2020 Current
Prashant Paleja Director 16 Aug 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 26 Feb 2024 Past
Pramod Abcsdd Additional Director 30 Nov 2021 Past
Pramod Abcsdd Director 26 Feb 2021 Past
Pramod Abcsdd Additional Director 27 Sep 2024 Past
Pramod Abcsdd Additional Director 27 Sep 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rimedio Pharma.

Rimedio Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 100% decrease in profit. The company's net worth observed a substantial decline by a decrease of 400%.

Rimedio Pharma revenue growth over time
Rimedio Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -50.00%
*******
*******
*******
*******
Profit or Loss
*******
 -100.00%
*******
*******
*******
*******
Net Worth
*******
 -400.00%
*******
*******
*******
*******
EBITDA
*******
 -75.00%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rimedio Pharma?

In 2022, Rimedio Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Rimedio Pharma?

Rimedio Pharma has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rimedio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rimedio Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rimedio Pharma
Recent Activity within the Organization
  • Director Appointment

    Satyendra Tiwari was appointed as a Additional Director was appointed as a Additional Director on 10 Feb 2025 & has been associated with this company since 1 year 16 days . was recorded as a recent event.

  • Annual General Meeting

    The activity Rimedio Pharma Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Rimedio Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.

  • Director Appointment

    Amit Mangilal Bishnoi was appointed as a Additional Director was appointed as a Additional Director on 26 Mar 2024 & has been associated with this company since 1 year 11 months . was recorded as a recent event.

  • Director Appointment

    Progress on Prashant Paleja was appointed as a Director was appointed as a Director on 16 Aug 2023 & has been associated with this company since 2 years 6 months . was documented.

  • Director Appointment

    The activity Kaushik Balakrishnan Natesan was appointed as a Director was appointed as a Director on 26 Mar 2020 & has been associated with this company since 5 years 11 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rimedio Pharma Private Limited?

The CIN of Rimedio Pharma Private Limited is U51909MH2020PTC339123.

Where is Rimedio Pharma Private Limited headquartered?

Rimedio Pharma Private Limited is headquartered at Unit No. 605/606, 6Th Floor, Trade Centre Bandra Kurla Complex, Bandra East Mumbai, Mumbai, Maharashtra, 400051.

When was Rimedio Pharma Private Limited incorporated?

Rimedio Pharma Private Limited was incorporated on 26 March 2020.

Who are the current directors of Rimedio Pharma Private Limited?

The current directors of Rimedio Pharma Private Limited are

What is the primary industry of Rimedio Pharma Private Limited?

The primary industry of Rimedio Pharma Private Limited is Trade.

Is Rimedio Pharma Private Limited a listed company?

Rimedio Pharma Private Limited is unlisted.

What is the capital structure of Rimedio Pharma Private Limited?

The authorized capital of Rimedio Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available